There are thousands of unapproved animal drugs on the market, a reality that concerns both the U.S. Food and Drug Administration and the AVMA. As veterinarians, we rely on FDA-approved drugs, as well as some unapproved animal drugs, to treat our patients, whether they’re food animals or family pets. The AVMA shares the FDA’s anxiety over drugs that are illegally marketed and have not gone through the rigors of the FDA approval process. But we also are committed to the continued availability of animal drugs that are pure, safe and effective.
The FDA is looking for ways to increase the number of legally marketed animal drugs, while also maintaining veterinarians’ access to essential unapproved animal drugs. We support their efforts, and we have offered our expertise to the FDA as the agency looks to determine the prevalence of unapproved animal drugs and how to increase the supply of drugs that have gone through the approval process.
The FDA will be hosting a webinar for AVMA members on January 26, from 11 a.m. to noon EST, titled, “What You Need to Know: FDA-Approved vs. Unapproved Animal Drugs,” that will help inform veterinarians about the agency’s activities to address the issue.
As part of the webinar, the FDA is accepting questions on unapproved animal drugs through January 12. FDA representatives conducting the webinar will try to answer as many of the questions during the webinar as time allows. AVMA members should be certain to send their emailed questions to AskCVM@fda.hhs.gov, with “AVMA/Unapproved Animal Drugs” as the subject line of the email.
The FDA has generously provided 1,000 lines for AVMA member veterinarians to listen to the webinar live online, on a first-come, first-served basis. The agency has also made arrangements that will allow up to 100 AVMA members to call in to the webinar toll free at 866-556-9888 using access code 4582566. The webinar also will be recorded and available on the FDA’s website, a link to which will be available on the AVMA website.